D-β-Hydroxybutyrate and melatonin for treatment of porcine hemorrhagic shock and injury: A melatonin dose-ranging study

Andrea Wolf; Kristine E. Mulier; Sydne L. Muratore; Gregory J. Beilman

doi:10.1186/s13104-017-2975-0

D-β-Hydroxybutyrate and melatonin for treatment of porcine hemorrhagic shock and injury: A melatonin dose-ranging study

Andrea Wolf, Kristine E. Mulier, Sydne L. Muratore, Gregory J. Beilman

Surgery

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Abstract

Objective: Treatment with a combination of d-β-hydroxybutyrate (BHB) and melatonin (M) improves survival in hemorrhagic shock models. Our objective was to find the most effective melatonin concentration in combination with 4 molar BHB (4 M BHB). Survival and markers of organ injury were analyzed in pigs exposed to pulmonary contusion, liver crush injury, and hemorrhagic shock and treated with lactated Ringer's solution; 4 M BHB/43 mM M; 4 M BHB/20 mM M; 4 M BHB/10 mM M; 4 M BHB/4.3 mM M; or 4 M BHB/0.43 mM M. This work is an extension of a previously published research study. Results: Survival was highest in pigs receiving 4 M BHB/43 mM M (13/14), followed by lactated Ringer's solution (11/16) and BHB/M with decreased melatonin concentrations (4 M BHB/20 mM M 3/6, 4 M BHB/10 mM M 2/6, 4 M BHB/4.3 mM M 3/6, 4 M BHB/0.43 mM M 1/6, p = 0.011). High mortality was associated with increases in serum lactate, higher liver and muscle injury markers and decreases in PaO₂:FiO₂ ratios. Our study indicates that treatment with 4 M BHB and melatonin concentrations below 43 mM lack the survival benefit observed from 4 M BHB/43 mM melatonin in pigs experiencing hemorrhagic shock and polytrauma.

Original language	English (US)
Article number	649
Journal	BMC Research Notes
Volume	10
Issue number	1
DOIs	https://doi.org/10.1186/s13104-017-2975-0
State	Published - Nov 29 2017

Bibliographical note

Funding Information:
This work was supported by USDOD ARMY, Grant W81XWH-10-2-0121. Research reported in this publication was also supported by the National Center for Advancing Translational Sciences of the National Institutes of Health Award Number UL1TR000114. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Publisher Copyright:
© 2017 The Author(s).

Keywords

Antioxidant
Blood loss
Hibernation
Ketone bodies
Melatonin
Resuscitation

Access

10.1186/s13104-017-2975-0

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5707828

OpenUrl availability

Full text

Cite this

@article{9c259beaba2d4dfcaeafd75dfd3120be,

title = "D-β-Hydroxybutyrate and melatonin for treatment of porcine hemorrhagic shock and injury: A melatonin dose-ranging study",

abstract = "Objective: Treatment with a combination of d-β-hydroxybutyrate (BHB) and melatonin (M) improves survival in hemorrhagic shock models. Our objective was to find the most effective melatonin concentration in combination with 4 molar BHB (4 M BHB). Survival and markers of organ injury were analyzed in pigs exposed to pulmonary contusion, liver crush injury, and hemorrhagic shock and treated with lactated Ringer's solution; 4 M BHB/43 mM M; 4 M BHB/20 mM M; 4 M BHB/10 mM M; 4 M BHB/4.3 mM M; or 4 M BHB/0.43 mM M. This work is an extension of a previously published research study. Results: Survival was highest in pigs receiving 4 M BHB/43 mM M (13/14), followed by lactated Ringer's solution (11/16) and BHB/M with decreased melatonin concentrations (4 M BHB/20 mM M 3/6, 4 M BHB/10 mM M 2/6, 4 M BHB/4.3 mM M 3/6, 4 M BHB/0.43 mM M 1/6, p = 0.011). High mortality was associated with increases in serum lactate, higher liver and muscle injury markers and decreases in PaO2:FiO2 ratios. Our study indicates that treatment with 4 M BHB and melatonin concentrations below 43 mM lack the survival benefit observed from 4 M BHB/43 mM melatonin in pigs experiencing hemorrhagic shock and polytrauma.",

keywords = "Antioxidant, Blood loss, Hibernation, Ketone bodies, Melatonin, Resuscitation",

author = "Andrea Wolf and Mulier, {Kristine E.} and Muratore, {Sydne L.} and Beilman, {Gregory J.}",

note = "Funding Information: This work was supported by USDOD ARMY, Grant W81XWH-10-2-0121. Research reported in this publication was also supported by the National Center for Advancing Translational Sciences of the National Institutes of Health Award Number UL1TR000114. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Publisher Copyright: {\textcopyright} 2017 The Author(s).",

year = "2017",

month = nov,

day = "29",

doi = "10.1186/s13104-017-2975-0",

language = "English (US)",

volume = "10",

journal = "BMC Research Notes",

issn = "1756-0500",

publisher = "BioMed Central",

number = "1",

}

TY - JOUR

T1 - D-β-Hydroxybutyrate and melatonin for treatment of porcine hemorrhagic shock and injury

T2 - A melatonin dose-ranging study

AU - Wolf, Andrea

AU - Mulier, Kristine E.

AU - Muratore, Sydne L.

AU - Beilman, Gregory J.

N1 - Funding Information: This work was supported by USDOD ARMY, Grant W81XWH-10-2-0121. Research reported in this publication was also supported by the National Center for Advancing Translational Sciences of the National Institutes of Health Award Number UL1TR000114. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Publisher Copyright: © 2017 The Author(s).

PY - 2017/11/29

Y1 - 2017/11/29

N2 - Objective: Treatment with a combination of d-β-hydroxybutyrate (BHB) and melatonin (M) improves survival in hemorrhagic shock models. Our objective was to find the most effective melatonin concentration in combination with 4 molar BHB (4 M BHB). Survival and markers of organ injury were analyzed in pigs exposed to pulmonary contusion, liver crush injury, and hemorrhagic shock and treated with lactated Ringer's solution; 4 M BHB/43 mM M; 4 M BHB/20 mM M; 4 M BHB/10 mM M; 4 M BHB/4.3 mM M; or 4 M BHB/0.43 mM M. This work is an extension of a previously published research study. Results: Survival was highest in pigs receiving 4 M BHB/43 mM M (13/14), followed by lactated Ringer's solution (11/16) and BHB/M with decreased melatonin concentrations (4 M BHB/20 mM M 3/6, 4 M BHB/10 mM M 2/6, 4 M BHB/4.3 mM M 3/6, 4 M BHB/0.43 mM M 1/6, p = 0.011). High mortality was associated with increases in serum lactate, higher liver and muscle injury markers and decreases in PaO2:FiO2 ratios. Our study indicates that treatment with 4 M BHB and melatonin concentrations below 43 mM lack the survival benefit observed from 4 M BHB/43 mM melatonin in pigs experiencing hemorrhagic shock and polytrauma.

AB - Objective: Treatment with a combination of d-β-hydroxybutyrate (BHB) and melatonin (M) improves survival in hemorrhagic shock models. Our objective was to find the most effective melatonin concentration in combination with 4 molar BHB (4 M BHB). Survival and markers of organ injury were analyzed in pigs exposed to pulmonary contusion, liver crush injury, and hemorrhagic shock and treated with lactated Ringer's solution; 4 M BHB/43 mM M; 4 M BHB/20 mM M; 4 M BHB/10 mM M; 4 M BHB/4.3 mM M; or 4 M BHB/0.43 mM M. This work is an extension of a previously published research study. Results: Survival was highest in pigs receiving 4 M BHB/43 mM M (13/14), followed by lactated Ringer's solution (11/16) and BHB/M with decreased melatonin concentrations (4 M BHB/20 mM M 3/6, 4 M BHB/10 mM M 2/6, 4 M BHB/4.3 mM M 3/6, 4 M BHB/0.43 mM M 1/6, p = 0.011). High mortality was associated with increases in serum lactate, higher liver and muscle injury markers and decreases in PaO2:FiO2 ratios. Our study indicates that treatment with 4 M BHB and melatonin concentrations below 43 mM lack the survival benefit observed from 4 M BHB/43 mM melatonin in pigs experiencing hemorrhagic shock and polytrauma.

KW - Antioxidant

KW - Blood loss

KW - Hibernation

KW - Ketone bodies

KW - Melatonin

KW - Resuscitation

UR - http://www.scopus.com/inward/record.url?scp=85036494990&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85036494990&partnerID=8YFLogxK

U2 - 10.1186/s13104-017-2975-0

DO - 10.1186/s13104-017-2975-0

M3 - Article

C2 - 29187245

AN - SCOPUS:85036494990

SN - 1756-0500

VL - 10

JO - BMC Research Notes

JF - BMC Research Notes

IS - 1

M1 - 649

ER -

D-β-Hydroxybutyrate and melatonin for treatment of porcine hemorrhagic shock and injury: A melatonin dose-ranging study

Abstract

Bibliographical note

Keywords

Access

OpenUrl availability

Other files and links

Fingerprint

Cite this